StockData
Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc. (TARA) stock

TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$2.32−0.06 (-2.52%)

Close on Nov 17, 2026Market cap $137.10MP/E –Yield –

Protara Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2014 it was -257.1%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2014Dec 31, 2014-257.1%–

More Protara Therapeutics figures

See a number that looks wrong?